
M-CH-00002396 (März 2023)
Verweise
- FoundationOne®CDx Technical Specifications, 2021. www.foundationmedicine.com/test/foundationone-cdx (accessed Feb 2022).
- FoundationOne®Liquid CDx Technical Specifications, 2021. https://www.foundationmedicine.com/test/foundationone-liquid-cdx (accessed Feb 2022).
- FoundationOne®Heme Technical Specifications, 2021. www.foundationmedicine.com/genomic-testing/foundation-one-heme (accessed Feb 2022).
- FoundationOne® Liquid CDx Technical Information. https://assets.ctfassets.net/w98cd481qyp0/3a8jFw3KUjIU3RWPdcT9Ax/52303a23af6cfbb7a899c90fcb4c22df/FoundationOne_Liquid_CDx_Label_Technical_Info.pdf (accessed Feb 2023).
- FoundationOne Liquid CDx, Press Release, Roche DE, 2020. https://www.roche.com/media/releases/med-cor-2020-08-28 (accessed Feb 2023).
- Woodhouse R, Li M, Hughes J, Delfosse D, Skoletsky J, Ma P, et al. (2020) Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin. PLoS ONE 15(9): e0237802. https://doi.org/10.1371/journal.pone.0237802
- FoundationOne Liquid CDx FDA Approval, 2020. Available at: www.foundationmedicine.com/press-releases/445c1f9e-6cbb-488b-84ad-5f133612b721 (Accessed August 2020).